Stamford, CT -- (SBWIRE) -- 10/24/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: Volkswagen AG (ADR) (OTCMKTS:VLKAY), InvenSense Inc (NYSE:INVN), Cell Therapeutics Inc (NASDAQ:CTIC), LSI Corp (NASDAQ:LSI)
Volkswagen AG (ADR) (OTCMKTS:VLKAY) ended lower -1.03% and complete the day at $47.20. The total number of shares changed hands during the day was 47.20 million. After opening at $47.06, the stock hit as high as $47.23. However, it traded between $34.30 and $48.35 over the last twelve months. Volkswagen AG, together with its subsidiaries, engages in the manufacture and sale of automobiles worldwide. The company operates in four segments: Passenger Cars and Light Commercial Vehicles; Trucks and Buses; Power Engineering; and Financial Services.
Has VLKAY Found The Bottom and Ready To Move Up? Find Out Here
InvenSense Inc (NYSE:INVN) closed yesterday at $19.19, a -5.23% decrease. Around 3.88 million shares were traded, beating an-average trading volume of 2.89 million shares. The company is now valued at around $1.66 billion. InvenSense, Inc. designs, develops, markets, and sells micro-electro-mechanical system (MEMS) gyroscopes for motion tracking devices in consumer electronics.
Has INVN Found The Bottom And Ready To Gain Momentum? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) moved -2.66 percent lower at $1.83 and traded between $1.80 and $1.85 after opening the day at $1.84. Its performance over the last five days remained -4.19%, which stands at +35.56% for a month. Going back further than one month, 1-year performance after recent close was +40.77%. Cell Therapeutics, Inc. engages in the acquisition, development, and commercialization of treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Why Should Investors Buy CTIC After the Recent Fall? Just Go Here and Find Out
LSI Corp (NASDAQ:LSI)’s shares decreased, -2.78 percent to close at $7.70. The stock is up around +8.98% this year and +19.27% for the last 12 months. Around 7.48 million shares changed hands yesterday, higher from an-average trading volume of 4.51 million shares. LSI Corporation designs, develops, and markets storage and networking semiconductors worldwide. Its storage product portfolio includes hard disk, solid state, and tape drive solutions, which enable the reading and writing of digital data to and from the storage media, such as the hard disk drive platter or the flash memory cell.
Will LSI Get Buyers Even After The Recent Rally? Find Out Here
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)